J. Biol. Chem., Vol. 261, Issue 22, 10073-10078, Aug, 1986
Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation
CS King and JA Cooper
The possible role of epidermal growth factor (EGF) receptor phosphorylation
at threonine 654 in modulating the protein-tyrosine kinase activity of
EGF-treated A431 cells has been studied. It has been suggested that EGF
could indirectly activate a protein-serine/threonine kinase, protein kinase
C, that can phosphorylate the EGF receptor at threonine 654. Protein kinase
C is known to be activated, and threonine 654 is phosphorylated, when A431
cells are exposed to 12-O- tetradecanoylphorbol-13-acetate (TPA). The
protein-tyrosine kinase activity of EGF receptors is normally evidenced in
EGF-treated cells by phosphorylation of the receptor at tyrosine. This is
inhibited when TPA- treated cells are exposed to EGF. We now show that
receptor phosphorylation at threonine 654 can also be detected in
EGF-treated A431 cells, presumably due to indirect stimulation of protein
kinase C or a similar kinase. Some receptor molecules are phosphorylated
both at threonine 654 and at tyrosine. Since prior phosphorylation at
threonine 654 inhibits autophosphorylation, we propose that protein kinase
C can phosphorylate the threonine 654 of autophosphorylated receptors. This
provides evidence for models in which protein kinase C activation,
consequent upon EGF binding, could reduce the protein-tyrosine kinase
activity of the EGF receptor. Indeed, we find that 12-O-
tetradecanoylphorbol-13-acetate, added 10 min after EGF, further increases
threonine 654 phosphorylation and induces the loss of tyrosine phosphate
from A431 cell EGF receptors.